Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
44m
Novo Nordisk beats on Wegovy sales, expects slower 2025 growth
Novo's earnings results Wednesday differ from Eli Lilly's, whose stock slid on slower-than-expected sales of weight loss ...
27m
on MSN
Are celeb-favorite weight loss drugs killing marriages? Shocking side effects revealed
Celebrities' use of weight loss drugs like Ozempic and Wegovy has surged, including Sharon Osbourne and Elon Musk. However, ...
Hosted on MSN
4m
Novo Nordisk Jumps After Ozempic Decidedly Beats. But 'Periodic Supply Constraints' Expected.
Novo Nordisk stock jumped early Wednesday after the weight-loss drugs leader reported adjusted earnings of 88 cents per share ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Places global staff on leave
Arrested on multiple charges
Ohio warehouse shooting
Plans to take over Gaza
Key Bridge design unveiled
Sued by former nanny
Spiritual leader dies
Eggs worth $40K stolen
Offers buyouts to workforce
Google drops AI pledge
Announces death of mother
Neo-Nazi leader convicted
World War II pilot dies
Mimics moon’s gravity
Hyde announces retirement
Adds surcharge to eggs
Wins Senate committee vote
Baby elephant at OR Zoo
FBI agents sue DOJ
To launch streaming service
Senate confirms Bondi as AG
FireAid raises over $100M
Confirmed as VA secretary
All 67 bodies recovered
Atmospheric river slams CA
Neil Jacobs to lead NOAA
US begins migrant flights
US job openings fall
Related topics
Novo Nordisk
Josh Gad
General Pharmaceutical Council
Feedback